Frisk, Bente
Jürgensen, Marte
Espehaug, Birgitte
Njøten, Kiri Lovise
Søfteland, Eirik
Aarli, Bernt Bøgvald
Kvale, Gerd
Funding for this research was provided by:
University of Bergen
Article History
Received: 15 March 2023
Accepted: 26 May 2023
First Online: 9 June 2023
Competing interests
: Bernt Bøgvald Aarli has received Grants, consulting fees or honoraria from Boehringer Ingelheim, GlaxoSmithKline, Astra Zeneca, Novartis and Sanofi-Aventis. Bente Frisk, Marte Jürgensen, Birgitte Espehaug, Kiri Lovise Njøten, Eirik Søfteland and Gerd Kvale have none competing interests.